The metabolic dealkylation of nine nitrosodialkylamines, including five symmetrical (nitrosodimethylamine, nitrosodiethvlamine, nitrosodipropylamine, nitrosodibutylamine and nitrosodiamylamine) and four asymmetrical nitrosodialkylamines (nitrosomethylethylamine, nitrosomethylpropylamine, nitrosomethylbutylamine and nitrosomethylamylamine), was investigated in 14 samples of human liver microsomes. All these nitrosodialkylamines were dealkylated to aldehydes that were separated by reversed phase HPLC and UV detected as dinitrophenylhydrazones. As the length of the alkyl chain increased from methyl to pentyl, dealkylation of symmetrical nitrosodialkylamines became less efficiently catalyzed by cytochrome P450. Conversely, oxidation of the methyl moiety of asymmetrical nitrosomethylalkylamines increased with the size of the alkyl moiety, while dealkylation of the longer alkyl group decreased. N-Dealkylase activities were significantly correlated with P450 activities measured in human liver microsomes. These catalytic activities involve CYP2A6 (coumarin 7-hydroxylation), CYP2C (mephenytoin 4-hydroxylation and tolbutamide hydroxylation), CYP2D6 (dextromethorphan O-demethylation), CYP2E1 (chlorzoxazone and pnitrophenol hydroxylation) and CYP3A4 (nifedipine oxidation). By using 10 heterologously expressed P450s, it was shown that nitrosodimethylamine was mainly demethylated by CYP2E1. However, such enzyme specificity was lost with increasing size of the alkyl group. Therefore, the chain length of the alkyl group of nitrosodialkylamines determined the P450 involved in its oxidation. All these results emphasize that the catalytic site of P450 2E1 has a geometric configuration such that only small molecules like nitrosodimethylamine fit favorably within the putative active site of the enzyme. Furthermore, there is good evidence that P450s other than P450 2E1, such as P450 2A6, 2C8/2C9/2C19 and 3A4, are involved in the metabolism of nitrosodialkylamines bearing bulky alkyl chains.
Introduction
Nitrosamines are carcinogenic compounds occurring widely in the environment. They require metabolic activation for their cytotoxic and carcinogenic actions. The major activation step for nitrosodialkylamines is hydroxylation of the a-carbon atom catalyzed by cytochromes P450 (P450 or CYP: individual forms of P450 are designated according to the nomenclature recommended by Nelson etal; 1) (2) . This metabolic activation is believed to be an important factor in determining the tissue and species specificities of these compounds. The substrate specificity based upon the size of the alkyl group of nitrosodialkylamines has in part been previously studied (3) . By using two nitrosodialkylamines, such as nitrosomethylethylamine (NMEA) and nitrosomethylpropylamine (NMPA), these studies established that P450 2E1 was the main enzyme involved in the dealkylation of nitrosodialkylamines, especially compounds bearing small alkyl chains (4) .
The metabolism of nitrosodialkylamines bearing small alkyl groups has been widely studied in the rat and humans using liver microsomal preparations (5-7). P450 2E1 is the major enzyme catalyzing the N-dealkylation of short chain nitrosodialkylamines in several animal species, including man (5, (8) (9) (10) (11) . P450 2E1 metabolizes a wide range of organic solvents, such as ethanol, benzene, carbon tetrachloride and trichloroethylene (9) . Hepatic CYP2E1 levels are increased in diabetic and starved states and are inducible by ethanol, organic solvents and pyrazole (12) .
Although, the metabolism of nitrosodialkylamines has been studied in human liver microsomes, the influence of the length of the alkyl chain has not been thoroughly investigated. Thus, the present study was undertaken to investigate the role of the alkyl group in determining P450 enzyme specificity. For that purpose, the metabolism of nine nitrosodialkylamines, including five symmetrical and four asymmetrical nitrosamines, was investigated using 14 human liver microsomal preparations and by means of 10 heterologously expressed P450s.
Materials and methods

Chemicals
Nitrosodimethylamine (NDMA), NMEA, nitrosodiethylamine (NDEA), NMPA, nitrosodipropylamine (NDPA), nitrosomethylbutylamine (NMBA) and nitrosodibutylamine (NDBA) were purchased from Sigma Chemical Co. (St Louis, MO). Nitrosodiamylamine (NDAA) was from NCI Chemical Carcinogen Reference Repository (Kansas City, MO). Nitrosomethyl n-amylamine (NMAA) was a gift of Dr S.Mirvish (University of Nebraska, NE). Solvents were of HPLC grade from Merck (Darmstadt, Germany) and all reagents were of analytical grade.
Human liver samples and microtome preparation
Human liver samples were obtained from 14 adult kidney donors (13 males and one female, mean age ± SD 37 ± 12 years) who died after traffic accidents. Sampling was in accordance with French legal considerations. Ethical Committee approval was obtained prior to this study. At brain death, the liver was removed, frozen immediatly in dry ice and then stored in liquid nitrogen until use for preparation of microsomes. Microsomal fractions were prepared as previously described (13) and stored at -80°C until use. The specific forms of P450 involved in different monooxygenation reactions have 1A1  1A2  2A6  2B6  2C8  2C9  2C19  2D6  2E1  3A4   45  120  193  86  16  37  18  212  179  80 Ethoxyrcsorufin O-deethylase (EROD) Elhoxyresorufin O-deethylase (EROD) Coumarin 7-hydroxylase (COH) 7-ethoxy-4-trifluoromethyl coumarin deethylase 5-chloromethylfluorescein diethyl ether deethylase Diclofenac 4'-hydrolase S-mephenytoin 4'-hydroxylase (MEPH) (+) bufuralol l'-hydroxylase 4-nitrophenol hydroxylase (4-NP) Testosterone 6p^hydroxylase
Catalytic activities of cDNA expressed P450 were measured in microsomes from human B-lymphoblastoid cell line, AHH1 (expressed as nmol/min/mg protein or turnover number as min" 1 ).
been previously characterized in the human liver microsomes referenced here according to methods reported elsewhere (14) .
Heterologously expressed CYP proteins
Cell microsomes containing human P450 were purchased from Gentest Corporation (Wobum, MA). Human B lymphoblastoid cell lines transfected with human CYP 1A1, 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4 cDNA expressed high specific enzymatic activities, according to the supplier (Table I) .
Metabolic studies • analysis of aldehydes
Incubations with liver microsomes were performed in a 0.5 ml mixture containing 50 mM Tris buffer, pH 7.4, 5 mM MgCl 2 , 70 mM KCI, 4 mM nitrosamines as substrate, 0.5 mg microsomal proteins and 1 mM NADPH, which was added after 5 min pre-incubation at 37°C. Based on previous studies (5, 6) , the metabolism of the nitrosamines was studied at a substrate concentration of 4 mM. The incubation was run for 20 min at 37°C in a shaking water bath in 7 ml capped flasks. As semicarbazide has been shown to be a competitive inhibitor of NDMA demethylase (5), it was not added to the reaction medium to trap the aldehyde formed. The test tubes were capped with Teflon septa to minimize evaporation. Reactions were stopped by adding 1 ml 2.4 N HCIO4 introduced through the septum. To determine aldehydes, their 2,4-dinitrophenylhydrazones were prepared as previously described (15) . They were analyzed by high performance liquid chromatography after extraction with isooctane and evaporation to dryness under a nitrogen stream. The dry residue was dissolved in acetonitrile/water (60:40 v/v). A volume of 50 ul was injected into the HPLC column (Ultrasphere-ODS, 4.6X150 mm; Beckman, San Raimon, CA). The mobile phase consisted of acetonitrile/water (60:40). The flow rate was 1 ml/min (Merck L-6200A intelligent pump). UV detection was performed at 356 nm with a UV detector (Merck L-4250).
Other monooxygenase activities and P450 immunoquaniitation
Methoxyresorufin O-demethylase (MROD) and ethoxyresorufin O-deethylase (EROD) activities, specific to P450 1A2 and 1AI respectively were determined by spcctrofluorimetry according to Burke et al. (16) . Tolbutamide hydroxylase (TB) and S-mephenytoin 4-hydroxylase (MEPH) activities, specific to P450 2C9 and 2C19 respectively, were measured according to Relling et al. (17) . Dextromethorphan O-demethylation to dextrophan was determined using HPLC, according to Jacqz-Aignn et al. (18) . Chlorzoxazone 6-hydroxylation (CHZ), specific to P450 2E1, was measured according to Carrierc et al. (19) . 4-Nitrophenol hydroxylase (4-NP) activity was determined using HPLC, according to Tassaneeyakul et al. (20) . Nifedipine oxidation and toremifene A'-demethylation were carried out as previously described (14, 21) .Coumarin 7-hydroxylation (COH) was measured according to Creaven et al. (22) . P450 2E1 and 3A were immunoquantitated as previously described (14) .
Statistical analysis
Results were correlated using linear regression analysis. Correlations were considered to be statistically significant at P < 0.02. Such statistical analysis assumed a random Gaussian distribution in the population studied. The skewness of the population (1.08 for NDMA, 0.33 for NDEA and 0.062 for NMPA) allowed us to validate the statistical procedures.
Results
Activities for metabolism of nitrosodialkylamines
Nine nitrosodialkylamines (NDMA, NMEA, NDEA, NMPA, NDPA, NMBA, NDBA, NMAA and NDAA) were studied in 2030 order to determine the effect of alkyl chain length on the metabolic dealkylation rates. This study used 14 human liver microsomal preparations. Data reported in Table II are in agreement with these previously reported by Yoo et al. (5) . For instance, metabolic rates of NDMA and NMBA demethylation mesured at 4 mM concentration in their study were 0.90 ± 0.77 (n = 16) and 0.95 ± 1.03 (n = 4) respectively, versus 0.92 ± 0.14 (n = 14) and 0.73 ± 0.14 (n = 14) nmol/min/mg protein in the present study. The dealkylation of nitrosodialkylamines showed a wide interindividual variability of 7.6-and 3.8-fold for NDMA and NDEA respectively. This variability increased dramatically for demethylation of asymmetrical dialkylnitrosamines, i.e. to 11.2-, 26-and 48-fold for NMEA, NMPA and NMBA respectively. Figure 1 represents the variation in metabolic rates of asymmetrical and symmetrical nitrosamines with the length of alkyl chain. Demethylation rates for NMEA and NMPA represented ~0.2-fold the dealkylation rates for the longest alkyl group of these molecules. As the alkyl chain increased in asymmetrical nitrosamines, formaldehyde formation increased in a manner such that the curves representing the formation of formaldehyde and higher aldehydes intersected. Dealkylation decreased dramatically as the alkyl group increased in symmetrical nitrosodialkylamines. All these results suggest that only small alkyl chains fit favorably with the putative active site of CYP2E1, while nitrosamines bearing bulky alkyl groups are metabolized by P450 isoforms other thanP450 2El.
Metabolism of nitrosamines by heterologously expressed P450 proteins
Microsomal preparations of human cells genetically engineered for stable expression of human P450s were used to catalyze the /V-dealkylation of nitrosamines. Ten P450s, including 1 Al, 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4, were shown to be able to hydroxylate the cc-carbon atom of the alkyl chain at varying metabolic rates (Table III) . The results, expressed as turnover number (per min or pmol/min/pmol P450), confirmed that P450 2E1 is the major P450 involved in the metabolic activation of NDMA. This substrate specificity was lost as the alkyl chain increased in size ( Figure 2 and Table III ). For example, NMEA was hydroxylated on its methyl and ethyl groups by P450 2C, 2E1 and 3A4.
Correlation between nitrosodialkylamine metabolism and different monooxygenase activities in human liver microsomes
Results of the metabolism of nitrosodialkylamines by 10 heterologously expressed CYP proteins suggested that P450 2A6, 2C9, 2C19, 2D6, 2E1 and 3A4 could all be involved in the reaction at the 4 mM concentration used here. If two reactions are catalyzed by the same enzyme, then the rates should be correlated with each other when compared in a wide panel of microsomal preparations containing varying levels of the enzymes. Table IV reports correlation coefficients (r) for P450-dependent activities measured in 14 human liver microsomal preparations. The values of the correlation coefficient r confirmed the results of metabolism of nitrosodialkylamines by heterologously expressed P450 proteins, i.e. P450 isoforms other than P450 2E1 are involved in N-dealkylation of nitrosamines bearing bulky alkyl chains. NDMA demethylation was significantly correlated with P450 2E1 activities (CHZ and 4-NP) and with the liver content of P450 2E1. NDEA deethylation was highly correlated with COH, specific to P450 2A6; such a result is in agreement with the data of Camus et al. (6) . Table IV emphasizes that CYP2E1 is the isoform most commonly associated with metabolic activation of the symmetrical nitrosodialkylamines (NDMA, NDEA, NDPA, NDBA) except for NDAA. Similarly, hydroxylation of the methyl group leading to formaldehyde was significantly correlated with CHZ and 4-NP. NDAA depentylation was not correlated with P450 2E1 activity, emphasizing that the geometric hindrance of the pentyl group prevents the substrate penetrating into the active site of CYP2E1.
In addition to P450 2E1 and 2A6, other P450 isoforms were shown to be involved in nitrosamine dealkylation. P450 3A4 and P450 2C activities were highly correlated with dealkylation of nitrosamines bearing an ethyl group, namely NMEA and NDEA. P450 2D6 could be involved in nitrosamine activation in some samples, especially with NDEA as substrate. P450 1A1 and 1A2 were not clearly involved. Figure 3 reports correlations between the metabolism of some nitrosamines. NDMA demethylation, which is known to be P450 2E1 dependent, correlated significantly with the dealkylation of other symmetrical nitrosamines ( Figure 3A) , except for NMBA debutylation and NMAA and NDAA depentylation. NDPA depropylation correlated significantly with all other nitrosamine dealkylations, such as demethylation and depropylation of NMPA ( Figure 3B ), but not with NDAA depentylation.
Discussion
Nitrosodialkylamines have been shown to cause cancers at different sites of organs in experimental animals and should be considered as one of the most important groups of chemical carcinogens in the environment (23, 24) . Humans are exposed to these procarcinogens through food and smoking (24) . Initial Correlation coefficient, r, was calculated by the least squares regression method. Bold numbers (r S" 0.61) were significant i.e. P < 0.02.
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No of carbon atoms in the alkyl chain metabolic oxidation of nitrosamines by P450 enzymes may be critical in the causation of cancer in man (8) . P450 2E1 is the major catalyst for the metabolic activation of NDMA in rat (25) and human (5) liver microsomes. However, the role of other P450 isoforms in the bioactivation of other nitrosodialkylamines had not been thoroughly studied.
Nitrosodialkylamines were studied at 4 mM, a concentration far higher than the levels to which people might be exposed.
Such a concentration was used in order to validate our results in comparison with previous studies (5, 6) . Furthermore, UV detection was not sensitive enough to allow measurement of product yields at concentrations near to biological levels.
The procedures to identify the P450 isoforms involved in nitrosodialkylamine dealkylation involved the use of correlation studies and heterologously expressed P450 enzymes. It must be kept in mind that statistical analysis is limited by a number of caveats, such as false correlations. Despite such limitations, the approach of using correlations does suggest groupings of families of nitrosamine dealkylation with individual catalytic activities known to be specific to individual P450s.
The results presented in this study support the view that P450 2E1 is the main catalyst in the metabolic activation of nitrosodialkylamines bearing small alkyl chains in human liver microsomes. The only P450 with significant NDMA demethylation activity was P450 2E1, with a turnover number of 6.05/min" 1 . By taking into account the mean content of the P450 2E1 isoform in human liver microsomes of ~ 120 pmol/mg protein (26, 27) , it is estimated that mean NDMA demethylation would be -720 pmol/min/mg, quite close to the experimental value of 920 reported in this study. Moreover, other P450 isoforms, such as 2A6, 2D6, 3A4 and 2C, may be involved in the activation of nitrosamines, as suggested by the following lines of evidence. First, NDEA deethylation correlated with COH, a reaction known to be catalyzed by CYP2A6 in human liver microsomes (28) . Second, heterologously produced P450 2A6 showed an ability to metabolize NDEA. Finally, these results confirm the involvement of P450 2A6 in NDEA deethylation, as has been previously reported (6, 7) . Based upon the same observations, the contribution of P450 3A4 to the deethylation of nitrosamines bearing an ethyl group (NMEA and NDEA) was established. The P450 2C family was also involved in the metabolism of NMEA, NDEA and NDAA. By taking into account the mean content of P450 isoforms in human liver microsomes (26, 27) and especially of CYP 2C (155 pmol/mg protein), the contribution of the CYP 2C family to NMEA deethylation could represent 35% of the total activity. However, the contributions of P450 3A4 and 2C seem to be minor, since ketoconazole and sulfaphenazole, inhibitors specific for P450 3A4 and 2C respectively, inhibited no more than 25% of NMEA and NMBA demethylation (data not shown). The two members of the P450 1A family, namely 1A1 and 1A2, are not involved in the activation of nitrosodialkylamines. Indeed, the lack of correlation between EROD or MROD activities and nitrosamine metabolism and, on the other hand, their inability to dealkylate NDMA, NMEA and NMBA support this assertion. Such an observation is not consistent with results reported in rats (29) and also in humans (7) . This discrepancy could be due to the different nitrosamines studied (tobacco-related nitrosamines versus nitrosodialkylamines) and the method of measuring activation (genotoxic activity versus aldehyde formation). Taken together, our results suggest that, in addition to P450 2E1 and 2A6 involved in NDMA and NDEA dealkylation respectively, the P450 isoforms 3A4 and 2C could be involved in nitrosodialkylamine dealkylation. This study emphasizes the role of the length of the alkyl chain in the determination of substrate specificity. NDEA deethylation was the most active enzymatic activity, mainly catalyzed by P450 2A6. The second most active catalytic activity was NDMA demethylation, catalyzed by P450 2E1. As the length of the alkyl chain increased, the catalytic activity dramatically decreased and was negligible for NDAA. The active sites of P450 2E1 and 2A6 present similar conformations such that only nitrosamines bearing small alkyl chains like methyl or ethyl can be actively hydroxylated on their a-carbon by these two P450s. However, human P450 2E1 seems to be favored over P450 2A6 in the activation of NDMA and vice versa for NDEA, as has been previously suggested (7) .
The metabolic behavior of nitrosomethylalkylamines differed depending on whether the methyl or the alkyl group is taken into account. Demethylation became more active as the length of the alkyl chain increased. Indeed, formaldehyde formation from NMBA was nearly as active as from NDMA itself. Conversely, dealkylation of asymmetrical nitrosamines decreased as the length of the alkyl chain increased. Such behavior suggests that the active site of P450 2E1 presents a geometric configuration in such a way that only methyl, ethyl and propyl groups can be hydroxylated.
However, the conceptual model of the active site of P450 2E1, consisting of a substrate access channel and a substrate binding pocket, both of determined sizes (30) , allows an explanation of the presently observed results. Furthermore, the asymmetrical nitrosomethylalkylamines are speculated to be positioned in the active site as E (or trans) geometric isomers, enabling placement of the methyl group near the oxygen atom of the heme-dioxygen complex. However, more detailed theoretical research will be needed to address the geometric configuration of the active site of P450 2E1 (31) .
Finally, taken together, the data reported in this study suggest that A'-dealkylation of nitrosodialkylamines is catalyzed by CYP2E1, but also by other P450s, in human liver microsomes. The demethylation or dealkylation of asymmetrical or symmetrical nitrosodialkylamines appears to be dependent upon the length of the alkyl chain. Furthermore, there is good evidence that P450s other than P450 2E1, such as P450 2A6, P450 2C8/2C9/2C19 and P450 3A4, are involved in the metabolism of nitrosodialkylamines bearing bulky alkyl chains.
